Nightstar Therapeutics Competitors and Similar CompaniesClear all
Nightstar Therapeutics's competitors and similar companies include CRISPR Therapeutics.
 Nightstar Therapeutics Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. | |
Founding Date | Founding Date 2013 | Founding Date 2013 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations London, GB HQ Lexington, US | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US |
Employees | Employees 4774% increase | Employees 393 |
Financial | ||
Net income | Net income ($36.9m) (FY, 2018) | Net income ($581.6m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 99.6m | Total funding raised $ 127m |
For sources of this data, please see the company profile
View Company Profiles
CRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company